Please provide your email address to receive an email when new articles are posted on . A novel ridaforolimus-eluting stent was noninferior to a zotarolimus-eluting stent for the primary outcome of ...
Please provide your email address to receive an email when new articles are posted on . Abbott announced that its bioresorbable stent system was granted a CE Mark for the treatment of patients with ...
Sirolimus-eluting stents and paclitaxel-eluting stents, as compared with bare-metal stents, reduce the risk of restenosis. It is unclear whether there are differences in safety and efficacy between ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results